1. Akdal G, Dönmez B, Cakmakçi H, Yener GG. A case with cerebral thrombosis receiving tamoxifen treatment. Eur J Neurol. 2001; 8:723–724. PMID:
11784361.
Article
2. Awad IA, Little JR, Akarawi WP, Ahl J. Intracranial dural arteriovenous malformations : factors predisposing to an aggressive neurological course. J Neurosurg. 1990; 72:839–850. PMID:
2140125.
Article
3. Bushnell C. The cerebrovascular risks associated with tamoxifen use. Expert Opin Drug Saf. 2005; 4:501–507. PMID:
15934856.
Article
4. Cognard C, Casasco A, Toevi M, Houdart E, Chiras J, Merland JJ. Dural arteriovenous fistulas as a cause of intracranial hypertension due to impairment of cranial venous outflow. J Neurol Neurosurg Psychiatry. 1998; 65:308–316. PMID:
9728941.
Article
5. Cognard C, Gobin YP, Pierot L, Bailly AL, Houdart E, Casasco A, et al. Cerebral dural arteriovenous fistulas : clinical and angiographic correlation with a revised classification of venous drainage. Radiology. 1995; 194:671–680. PMID:
7862961.
Article
6. Cognard C, Januel AC, Silva NA Jr, Tall P. Endovascular treatment of intracranial dural arteriovenous fistulas with cortical venous drainage : new management using Onyx. AJNR Am J Neuroradiol. 2008; 29:235–241. PMID:
17989374.
Article
7. D'Angelo-Donovan D, Guarino MJ. Sagittal sinus thrombosis while on tamoxifen requiring craniectomy. Del Med J. 2012; 84:31–32. PMID:
22720357.
8. Davies MA, Saleh J, Ter Brugge K, Willinsky R, Wallace MC. The natural history and management of intracranial dural arteriovenous fistulae Part 1 : benign lesions. Interv Neuroradiol. 1997; 3:295–302. PMID:
20678360.
Article
9. Davies MA, Ter Brugge K, Willinsky R, Wallace MC. The natural history and management of intracranial dural arteriovenous fistulae Part 2 : aggressive lesions. Interv Neuroradiol. 1997; 3:303–311. PMID:
20678361.
Article
10. Davies MA, TerBrugge K, Willinsky R, Coyne T, Saleh J, Wallace MC. The validity of classification for the clinical presentation of intracranial dural arteriovenous fistulas. J Neurosurg. 1996; 85:830–837. PMID:
8893721.
Article
11. Duvelleroy Hommet C, De Toffol B, Corcia P, Autret A. Cerebral venous thrombosis and estrogen-progesterone therapy. Eur Neurol. 1998; 39:245–247. PMID:
9635480.
12. Fatehi F, Saadatnia M, Zare M. Cerebral venous sinus thrombosis following tamoxifen prescription. Neurosciences (Riyadh). 2008; 13:320. PMID:
21063352.
13. Finelli PF. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005; 353:314–315. PMID:
16038058.
Article
14. Finelli PF, Schauer PK. Cerebral sinus thrombosis with tamoxifen. Neurology. 2001; 56:1113–1114. PMID:
11320192.
Article
15. Halbach VV, Higashida RT, Hieshima GB, Rosenblum M, Cahan L. Treatment of dural arteriovenous malformations involving the superior sagittal sinus. AJNR Am J Neuroradiol. 1988; 9:337–343. PMID:
3128082.
16. King WA, Martin NA. Intracerebral hemorrhage due to dural arteriovenous malformations and fistulae. Neurosurg Clin N Am. 1992; 3:577–590. PMID:
1633481.
Article
17. Liu JK, Choudhry OJ, Barnwell SL, Delashaw JB Jr, Dogan A. Single stage transcranial exposure of large dural venous sinuses for surgically-assisted direct transvenous embolization of high-grade dural arteriovenous fistulas : technical note. Acta Neurochir. 2012; 154(Wien):1855–1859. PMID:
22865057.
Article
18. Masjuan J, Pardo J, Callejo JM, Andrés MT, Alvarez-Cermeño JC. Tamoxifen : a new risk factor for cerebral sinus thrombosis. Neurology. 2004; 62:334–335. PMID:
14745086.
Article
19. Meier CR, Jick H. Tamoxifen and risk of idiopathic venous thromboembolism. Br J Clin Pharmacol. 1998; 45:608–612. PMID:
9663819.
Article
20. Meyer MA. Cerebral sinus thrombosis with tamoxifen. Neurology. 2001; 57:2150. PMID:
11739856.
Article
21. Raizer JJ, DeAngelis LM. Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients. Neurology. 2000; 54:1222–1226. PMID:
10746588.
Article
22. Saphner T, Tormey DC, Gray R. Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol. 1991; 9:286–294. PMID:
1988575.
Article